[Skip to Content]
[Skip to Content Landing]
November 2001

Cyclosporine in Childhood Psoriasis

Arch Dermatol. 2001;137(11):1532-1533. doi:

Systemic therapies for severe childhood psoriasis have not been evaluated and are used empirically, and retinoids are considered a second line of therapy. The safety and efficacy of cyclosporine therapy have been extensively studied in severe adult and childhood atopic dermatitis and in adult psoriasis. We describe 4 patients who were treated with cyclosporine for severe drug-resistant psoriasis (neonatal erythrodermic psoriasis, acral pustular psoriasis, generalized pustular psoriasis, and very severe erythrodermic psoriasis). Because of unsatisfactory results, cyclosporine therapy was discontinued in all 4 cases. Despite the inefffectiveness of cyclosporine therapy in these unusual cases, we discuss a possible role for cyclosporine in the treatment of childhood psoriasis. Notably, higher doses of cyclosporine might be used in cases involving young children.

First Page Preview View Large
First page PDF preview
First page PDF preview